Stock listing
Syros Pharmaceuticals, Inc.
Selected listing: 0LC7 · LSE · USD · GB
Syros Pharmaceuticals, Inc. (LSE:0LC7), Health Technology. Latest release Jul 16, 2025: Quetzal Therapeutics Debuts with Expert Leadership, High-Impact…
- Ticker
- LSE:0LC7
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LSE
- Currency
- USD
About Syros Pharmaceuticals, Inc.
Syros Pharmaceuticals, Inc. (ticker: SYRS) is a public company based in the United States, focusing on the development of innovative therapies for cancer and other diseases. The company is committed to leveraging its proprietary gene control platform to discover and develop new treatment options.
Latest news from Syros Pharmaceuticals, Inc.
Events
Research Syros Pharmaceuticals, Inc.
Syros Pharmaceuticals, Inc. company profile
View the public company page for Syros Pharmaceuticals, Inc. on 6ix.
Syros Pharmaceuticals, Inc. news
Read company news and market updates connected to Syros Pharmaceuticals, Inc..
Syros Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Syros Pharmaceuticals, Inc..
Alternate listings
SYRS:OTC
US · USD
Alternate listing for Syros Pharmaceuticals, Inc.; the primary context on this page is 0LC7:LSE.
A3DT8V:LSX
DE · EUR
Alternate listing for Syros Pharmaceuticals, Inc.; the primary context on this page is 0LC7:LSE.
A3DT8V:LS
DE · EUR
Alternate listing for Syros Pharmaceuticals, Inc.; the primary context on this page is 0LC7:LSE.